Stockscreener 앱 받기
45.48
0.18%
-0.08
전일 마감가:
$45.56
열려 있는:
$45.45
하루 거래량:
1.06M
Relative Volume:
0.77
시가총액:
$9.77B
수익:
$1.98B
순이익/손실:
$83.59M
주가수익비율:
121.60
EPS:
0.374
순현금흐름:
$502.31M
1주 성능:
+0.78%
1개월 성능:
+7.85%
6개월 성능:
+1.83%
1년 성능:
-1.59%
1일 변동 폭
$45.28
$45.88
1주일 범위
$44.71
$46.19
52주 변동 폭
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
45.48 | 9.77B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
401.90 | 152.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.02 | 135.91B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.91 | 41.29B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.80 | 31.79B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
152.32 | 24.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
QGEN Partners with Tracer Biotechnologies to Advance Cancer Test - GuruFocus
QIAGEN (QGEN) Partners with Tracer Biotechnologies for MRD Assays - GuruFocus
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors - marketscreener.com
Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN
Qiagen, Tracer Biotechnologies announce strategic partnership - TipRanks
Transcript : Qiagen N.V. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 09 - marketscreener.com
Qiagen N.V. Reports Significant Voting Rights Held by BlackRock - TipRanks
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances - Nasdaq
Qiagen expands portfolio for minimal residual disease testing in oncology - BioSpectrum Asia
QIAGEN expands portfolio for MRD testing in oncology with two partnerships - Seeking Alpha
Foresight Diagnostics and Qiagen Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma - marketscreener.com
Qiagen Enters Partnerships, Expands Portfolio for Minimal Residual Disease Testing in Oncology - marketscreener.com
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships - Business Wire
Foresight Diagnostics And Qiagen Announce Strategic Partnership To Advance Development Of Companion Diagnostic Kits For Lymphoma - marketscreener.com
Qiagen (QGEN) Forms Strategic Alliance with Foresight Diagnostic - GuruFocus
Qiagen (QGEN) Forms Strategic Alliance with Foresight Diagnostics | QGEN Stock News - GuruFocus
Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma - marketscreener.com
Equities Analysts Set Expectations for Qiagen Q2 Earnings - Defense World
Ameriprise Financial Inc. Grows Stake in Qiagen (NYSE:QGEN) - Defense World
QIAGEN NV : Berenberg gives a Buy rating - marketscreener.com
Cetera Investment Advisers Acquires 1,418 Shares of Qiagen (NYSE:QGEN) - Defense World
Qiagen NV (QGEN) Trading 4% Higher on May 27 - GuruFocus
QIAGEN NV : Receives a Buy rating from DZ Bank - marketscreener.com
Cell-Free DNA Isolation and Extraction Market - GlobeNewswire Inc.
Europe Digital PCR Industry Research Report 2025: Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plans - GlobeNewswire Inc.
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research - Insider Monkey
QIAGEN expands digital PCR oncology research portfolio through p - GuruFocus
QGEN Stock Might Gain Following New Partnership With ID Solutions - TradingView
Qiagen and ID Solutions collaborate on dPCR assays for oncology research - Medical Device Network
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions - Silicon Canals
QIAGEN (QGEN) Expands dPCR Assay Availability Through New Partnership | QGEN Stock News - GuruFocus
QIAGEN acquires AI-powered software, Genoox - MSN
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Qiagen Receives Notification of BlackRock’s Voting Rights - TipRanks
QIAGEN Stock Gains Following the Acquisition of Genoox - MSN
Qiagen Stock Beats Earnings, But Its Expensive Valuation Caps Upside Potential (NYSE:QGEN) - Seeking Alpha
Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings - Yahoo Finance
BlackRock Increases Stake in Qiagen, Influencing Market Dynamics - TipRanks
Qiagen Receives Significant Voting Rights Notification from AFM - TipRanks
Qiagen’s Voting Rights Announcement Highlights BlackRock’s Influence - TipRanks
QIAGEN acquires Genoox to enhance genetic data analysis By Investing.com - Investing.com Nigeria
Qiagen Releases Q1 2025 Financial Report Highlighting Asset Decline - TipRanks
Pluri (NASDAQ:PLUR) & Qiagen (NYSE:QGEN) Head to Head Contrast - Defense World
Qiagen (QGEN) Expands Genomic Capabilities with Genoox Acquisiti - GuruFocus
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen Acquires Genoox for $70 Million - marketscreener.com
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
1.06%
자본화:
|
볼륨(24시간):